VIRTUAL CONFERENCE
From Gross to Net Estimates and Accruals to Preparing for an IPO to Government Pricing for Biotechs to Revenue Recognition examples and latest updates, this conference will address the latest developments in key areas. You’ll hear from experts at Deloitte, Ernst & Young, CFGI, life science analysts and your industry counterparts.
LEARNING OBJECTIVES:
- Understand the latest accounting changes in key areas
- Recognize the timelines and key factors affecting the life science industry
- Begin to assess the effects of these standards on your company or clients
REGISTRATION INFORMATION:
Cost: $545
This event will run approximately 8:45-4:40p (Eastern Time) each day.
Register any one of three ways:
1. Register online using a credit card and click the orange button
2. Register by phone at (610) 789-3110
3. Email your contact info to be invoiced to mtarman@acslive.com
| Agenda: DAY 1 | ||
|---|---|---|
| 8:45 | 10:00 | Inventory Accounting Update Operatibg the commecial inventory accounting and reporting program Readiness: roadmap, policies and procedures, internal controls, roles and responsibilities, product costing methodology, R&D and invenotriable expenses, tools and technology Day 1: closing the books, jounal entries, account reconciliations, executing controls, third party data, auditor considerations Run State: closing the books, journal entries, inventory tracking, management reporting, forecasting, inventory counts, valuation and standard costing, new products and growth |
| 10:00 | 10:10 | Break |
| 10:10 | 11:30 | Revenue Recognition Update Cases and examples Interaction of 808 and 606 Evaluating “active participation” Measure of progress SEC comment letter themes ASC 606 Implementation issues and lessons learned in the life science industry |
| 11:30 | 11:40 | Break |
| 11:40 | 1:05 | Technology Trends in Life Sciences Core Modernization Trust Business of Technology Data and Analytics and Artificial Intelligence Digital Experience and Digital Reality |
| 1:05 | 2:05 | Lunch |
| 2:05 | 3:05 | Accounting for R&D and New Product Launches R&D Funding Arrangements R&D Cost Classifications SEC Comment Letter Trends |
| 3:05 | 3:10 | Break |
| 3:10 | 4:40 | Tax Update Tax Policy Update Auditing Income Taxes COVID Impact - Remote Employees State Updates COVID Relief Section 382 |
| Agenda: DAY 2 | ||
|---|---|---|
| 8:50 | 10:05 | Lease Modifications under ASC 842 Discussion on future workplace & hybrid model of work Determining key assumptions in measuring the lease in this environment (e.g. discount rate) Evaluating certain transactions that may result from business interruption |
| 10:05 | 10:20 | Break |
| 10:20 | 11:40 | Fraud and Cybersecurity in Life Sciences Recent Trends Cases and Examples New threats from COVID Ransomware |
| 11:40 | 11:45 | Break |
| 11:45 | 1:00 | Accounting & Reporting Update: SEC Comment Letter themes MD&A Update Changing regulatory environment Non-GAAP measures ICFR material weaknesses Cybersecurity disclosures |
| 1:00 | 1:30 | Lunch |
| 1:30 | 2:55 | Valuation Update Fair value accounting Industry standards for valuation models Valuing IPR&D projects Valuation and impairment of intangible assets |
| 2:55 | 3:10 | Break |
| 3:10 | 4:40 | Trends in IPOs and SPAC Transactions Accounting considerations Typical steps IPO Trends Unicorns and timing give IPOs a lift Geopolitical and trade issues Outlook |
| Conference Series Speakers Include: |
|---|
| Skyler Kersten Deloitte, Manager |
| Marcus Lindner Ernst & Young, Senior Manager |
| Alex Bowen Deloitte, Manager |
| Andreas Chrysostomou Duff & Phelps, Managing Director - Global Leader - Healthcare Life Sciences Industry |
| Joseph Sutter Deloitte, Senior Manager |
| Jennifer Kimmel BDO, Director |
| Joseph Segoria Deloitte, Tax Partner |
| Dan Lujan Ernst & Young, Partner |
| Max Lewandowski BDO, Audit Director |
| Alex Wolf Deloitte, Senior Manager |
| Aleks Zabreyko Connor Group, Senior Technical Partner |
| Jon Goldblatt Duff & Phelps, Managing Director |
| Matt Lepley Connor Group, Director |
| Melissa de la Rosa Deloitte, Senior Manager |
| Shaunna Dangremond Ernst & Young, Senior Manager |
| Jeff Kummer Deloitte, Director of Tax Policy |
| Frank Deluccia Duff & Phelps, Director |
| David Law Deloitte, National Office Accounting Consultation |
| Christine Tutaj Ernst & Young, Senior Manager |
| Charlie Xu Deloitte, Manager - National Office, Professional Practice Network |
| Jade Dauser Tepe Ernst & Young, Corporate Real Estate and Technology Leader |
| David Nadell Duff & Phelps, Director |
| Andrew Debbink Ernst & Young, Manager |
| Patrick Hynes Ernst & Young, Principal |
| Arlene Mordeno Ernst & Young, Managing Director |